about
Termination of pregnancy for fetal abnormalities: main arguments and a decision-tree model.Value of maternal procalcitonin levels for predicting subclinical intra-amniotic infection in preterm premature rupture of membranes.Fetal circulatory variation in an acute incident causing bradycardia.Effects of HRT on serum levels of IGF-I in postmenopausal women.The values of urinary NTx in postmenopausal women undergoing HRT; the role of additional alendronate therapy.Reply to the Comment by Professor Jonathan D.C. Ross.A randomized controlled trial of coil removal prior to treatment of pelvic inflammatory disease.Tubo-ovarian abscess mimicking ovarian tumor in a sexually inactive girl.Umbilical coiling index: is it a marker for the foetus at risk?Effects of betamethasone and thyroid releasing hormone on fetal lung maturation: an experimental and morphometric study.Different maternal serum hCG levels in pregnant women with female and male fetuses: does fetal hypophyseal--adrenal--gonadal axis play a role?Regression of endometrial explants in rats treated with the cyclooxygenase-2 inhibitor rofecoxib.Comparison of uterine exteriorization and in situ repair during cesarean sections.Effects of transdermal estrogen replacement therapy on plasma levels of nitric oxide and plasma lipids in postmenopausal women.Raloxifene increases serum leptin levels in postmenopausal women: a prospective study.A prospective study on fetal posterior cranial fossa assessment for early detection of open spina bifida at 11-13 weeks.Early versus delayed oral feeding after cesarean delivery under different anesthetic methods--a randomized controlled trial anesthesia, feeding in cesarean delivery.Expression of IGR-IR and VEGF and trophoblastic proliferative activity in placentas from pregnancies complicated by IUGR.A prospective cohort study on the prediction of fetal distress and neonatal status with arterial and venous Doppler measurements in appropriately grown term fetuses.A prospective study on first trimester prediction of ischemic placental diseases.Pendrin Expression in Preeclampsia: A Prospective Immunohistochemical Staining Study on Placental Bed Biopsies.Neonatal outcome of fetuses receiving intrauterine transfusion for severe hydrops complicated by Rhesus hemolytic disease.Analysis of first-trimester combined test results in preparation for a cell-free fetal DNA era.Fetal gender affects maternal serum total and placental alkaline phosphatase levels during pregnancy.A prospective cohort study on the prediction of the diagnosis-to-delivery time in preeclamptic pregnancies: should the sFlt-1/PlGF ratio be added to routine evaluations?Do preeclampsia symptoms resolve after intrauterine death of a fetus?Abnormal patterns of blood flow through the uterine arteries: Is it a clue for placental abruption in clinically suspected cases?A comparative study of obstetric outcomes in electively or spontaneously reduced triplet pregnanciesDoes fetal gender affect cytotrophoblast cell activity in the human term placenta? Correlation with maternal hCG levelsMosaic form (45X/46XX) of Turner's syndrome. A case reportPrimary endometrioid adenocarcinoma with coexisting endometrial tuberculosis. A case reportOmentectomy, peritoneal biopsy and appendectomy in patients with clinical stage I endometrial carcinomaMay Cathepsin D Immunoreactivity Be Used as a Prognostic Factor in Endometrial Carcinomas? A Comparative Immunohistochemical StudyHydroxyurea treatment for chronic myeloid leukemia during pregnancy
P50
Q40681236-2A68DC5F-D7CC-416A-B475-6F8EF451552BQ42237571-9B7263C6-2F98-48CB-BEB8-A7A638970C5DQ43087478-E8E7B9CC-6942-4A3C-A6E4-A282BF9E3392Q43783093-879030D5-E17F-412C-88A1-AC9333AAEF9AQ44111502-8FF0BA23-9D50-4B08-830F-2FFADC664FF4Q44201901-ADE3BDF3-703C-430E-93F0-2C2EF886D65DQ44253018-E76BE8C6-E180-4B00-9EBC-C62DE1429EF0Q44294469-E761F42C-156A-4BEA-92D4-F258F39DD748Q44851877-E4B5AE88-CAE1-42AC-959F-8778DF1E422DQ44985343-6FDF149B-D726-4D03-9339-5018D9F7DE0FQ45043508-CD1203FF-19A2-4D2E-806C-3F24A0CBF208Q45098064-2ECFF0A4-A52D-4468-95C3-4EBB69C781A2Q45778587-F908C861-0299-46FD-A359-62E32328DB90Q46394040-8A9A2BC2-EBC0-4D28-8950-09BAC409C30EQ46649080-0475E908-D7BA-4F64-AAA4-DDE6A8B80B63Q47402045-420CC335-F2E9-4A3C-BFBB-817387CA7A41Q47749035-3F3BCAC1-FA1E-41DB-BA99-D917FB690A92Q48025402-C01AB8F4-3623-4498-8DBE-5EED11B063CBQ48127880-E7B13D5A-CC3A-48D4-96EE-6BDD9299E622Q48273707-B0A13F72-A3C3-4A1E-B993-AD604222CAB0Q48286752-774D0050-8BC8-4B7F-B8FC-DDFB4BAD0102Q50431454-08675B6C-69CD-4770-B2BB-79D38865FD61Q51546135-8001D710-34C6-463B-9550-63B60C3386E8Q51829244-01A2821E-326D-463A-9392-88D17B005C77Q58434419-586B6BFC-67B6-4E36-9856-C16176DC99EBQ58434441-F6CCD5FA-CC39-4A40-BFB1-7FA48467713DQ58434453-0F9AC916-D0F4-4926-95FC-42B12FC9D491Q58434470-CA2E7DDE-9E86-43F6-A611-2CE97BB34A95Q58434528-7BE98CCD-9A8B-4EF5-AEAD-AC928A335DA4Q58434546-BDB0C087-3B04-4BAF-B943-BF920D20EDCDQ58434556-06E98326-0786-4BCA-BA2B-B76A7A9DB964Q58434561-2D14E1F0-A919-46E8-A086-2B15DA77FED0Q58434571-B319FCEE-E08A-4CBB-90BA-EED7A9FF1445Q58434578-680555A0-1CA3-4AEC-953F-9A7674605B36
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
研究者
@zh
name
Sabahattin Altunyurt
@ast
Sabahattin Altunyurt
@en
Sabahattin Altunyurt
@es
Sabahattin Altunyurt
@nl
type
label
Sabahattin Altunyurt
@ast
Sabahattin Altunyurt
@en
Sabahattin Altunyurt
@es
Sabahattin Altunyurt
@nl
prefLabel
Sabahattin Altunyurt
@ast
Sabahattin Altunyurt
@en
Sabahattin Altunyurt
@es
Sabahattin Altunyurt
@nl
P106
P31
P496
0000-0002-8887-3097